Adverse pregnancy outcomes among pregnant women with hidradenitis suppurativa: a systematic review and meta-analysis
Clinical and Experimental Dermatology · 26.03.2026 · 51 (4) · 578-586
DOI: 10.1093/ced/llaf515 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Clinical and Experimental Dermatology, online erschienen am 21.11.2025. Verfasst von Yen-Ning Chen und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Chang Gung Memorial Hospital, Linkou Main Branch, Taoyuan, Taiwan. Hauptthemen laut MEDLINE: Hidradenitis Suppurativa, Pregnancy Outcome, Pregnancy Complications. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 57 Literaturangaben.
Abstract (Originalsprache)
Background
Hidradenitis suppurativa (HS) is a chronic inflammatory dermatosis primarily affecting women of reproductive age. HS may contribute to an increase of adverse pregnancy outcomes (APOs).
Objectives
To investigate the association of HS with APOs.
Methods
A systematic review was conducted of observational studies examining the association of maternal HS with APOs. We searched MEDLINE, Embase and CENTRAL from inception to 15 March 2025 for relevant studies. No restrictions were imposed on language or geographical regions. Observational studies, including cohort and case–control designs, which examined the odds or risk of APOs among pregnant patients were considered eligible for inclusion. The risk of bias was assessed using the Newcastle–Ottawa Scale. A random-effects model meta-analysis using the inverse-variance-weighted method was performed.
Results
We included four retrospective cohort studies with 15 189 175 pregnancies. The overall risk of bias was low to unclear. The meta-analysis revealed associations of HS with APOs, including gestational diabetes mellitus [odds ratio (OR) 1.46, 95% confidence interval (CI) 1.09–1.96], pre-eclampsia/eclampsia (OR 1.18, 95% CI 1.01–1.38), caesarean section (OR 1.31, 95% CI 1.04–1.64) and postpartum haemorrhage (OR 1.39, 95% CI 1.07–1.82). Regarding adverse fetal outcomes, maternal HS was significantly associated with spontaneous abortion (OR 1.19, 95% CI 1.06–1.34), preterm birth (OR 1.17, 95% CI 1.04–1.31) and birth defects (OR 1.47, 95% CI 1.03–2.11).
Conclusions
Pregnant women with HS have an increased risk of APOs, underscoring the need for coordinated care between dermatologists and obstetricians, as well as early diagnosis and intervention to mitigate potential risks to maternal health and fetal development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Dermatology, Chang Gung Memorial Hospital, Linkou Main Branch, Taoyuan, Taiwan.
- Department of Medical Education, Chang Gung Memorial Hospital, Linkou Main Branch, Taoyuan, Taiwan.
- Dr Chun-Min Lin's Dermatology Clinic, New Taipei, Taiwan.
- School of Medicine, College of Medicine, Chang Gung University, Taoyuan, Taiwan.
ORCID-Profile: Yen-Ning Chen, Chin-Hsuan Shen, Cheng-Chen Tai, Tzu-Yu Wang, Ching-Chi Chi
Zitieren
APA
Chen, Y. N., Shen, C. H., Tai, C. C., Wang, T. Y., & Chi, C. C. (2026). Adverse pregnancy outcomes among pregnant women with hidradenitis suppurativa: a systematic review and meta-analysis. Clinical and Experimental Dermatology, 51(4), 578-586. https://doi.org/10.1093/ced/llaf515
Vancouver
Chen YN, Shen CH, Tai CC, Wang TY, Chi CC. Adverse pregnancy outcomes among pregnant women with hidradenitis suppurativa: a systematic review and meta-analysis. Clinical and Experimental Dermatology. 2026;51(4):578-586. doi:10.1093/ced/llaf515
BibTeX
@article{Chen2026,
author = {Chen, Yen-Ning and Shen, Chin-Hsuan and Tai, Cheng-Chen and Wang, Tzu-Yu and Chi, Ching-Chi},
title = {Adverse pregnancy outcomes among pregnant women with hidradenitis suppurativa: a systematic review and meta-analysis},
journal = {Clinical and Experimental Dermatology},
year = {2026},
volume = {51},
number = {4},
pages = {578--586},
doi = {10.1093/ced/llaf515}
}
EUVIMED